Narendra D. Lalwani
2015
In 2015, Narendra D. Lalwani earned a total compensation of $3.2M as Executive Vice President, Research and Development and Chief Operating Officer at Esperion Therapeutics, a 1% increase compared to previous year.
Compensation breakdown
| Bonus | $127,000 |
|---|---|
| Option Awards | $2,722,224 |
| Salary | $370,000 |
| Other | $12,000 |
| Total | $3,231,224 |
Lalwani received $2.7M in option awards, accounting for 84% of the total pay in 2015.
Lalwani also received $127K in bonus, $370K in salary and $12K in other compensation.
Rankings
In 2015, Narendra D. Lalwani's compensation ranked 2,891st out of 13,638 executives tracked by ExecPay. In other words, Lalwani earned more than 78.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,891 out of 13,638 | 79th |
Division Manufacturing | 1,024 out of 5,190 | 80th |
Major group Chemicals And Allied Products | 379 out of 1,854 | 80th |
Industry group Drugs | 296 out of 1,528 | 81st |
Industry Pharmaceutical Preparations | 235 out of 1,182 | 80th |
Source: SEC filing on March 6, 2017.
Lalwani's colleagues
We found four more compensation records of executives who worked with Narendra D. Lalwani at Esperion Therapeutics in 2015.